[611] KETOPROFEN PLUS PEG-IFN ALPHA-2a AND RIBAVIRIN AS A TRIPLE TREATMENT FOR GENOTYPE 1 (G1) CHRONIC HEPATITIS C (CHC): RESULTS OF A PHASE II RANDOMIZED CONTROLLED TRIAL | Publicación